SwePub
Sök i LIBRIS databas

  Extended search

L773:1600 0560 OR L773:0303 6987
 

Search: L773:1600 0560 OR L773:0303 6987 > PD-1 and PD-L1 in n...

  • Mitteldorf, C. (author)

PD-1 and PD-L1 in neoplastic cells and the tumor microenvironment of Merkel cell carcinoma

  • Article/chapterEnglish2017

Publisher, publication year, extent ...

  • 2017-06-22
  • Blackwell Publishing Ltd,2017
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:miun-44511
  • https://urn.kb.se/resolve?urn=urn:nbn:se:miun:diva-44511URI
  • https://doi.org/10.1111/cup.12973DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Background: Merkel cell carcinoma (MCC) is an aggressive neoplasm, which is often associated with Merkel cell polyomavirus (MCPyV). Programmed death-1 (PD-1) and its ligand PD-L1 are key players of the tumor microenvironment (TME). Methods: Fourteen paraffin-embedded tissue samples of MCC were stratified by their MCPyV detection. Apart from PD-L1 and PD-1, the TME was further characterized for the expression of CD33, FOXP3 and MxA. Results: We observed PD-1 in 2 of 12 tumors. PD-L1 expression by tumor cells was found in 7 of 8 MCPyV(+) samples and was detected particularly in the periphery. The tumor cells were surrounded by a shield of PD-L1/CD33 immune cells. Expression of PD-L1 by the tumor cells was higher in areas with a denser immune infiltrate. CD33(+) cells without direct tumor contact were PD-L1 negative. Only a low number of FOXP3(+) regulatory T-cells was admixed. Tumor cells of MCPyV(−) samples were mostly PD-L1 negative. Conclusions: Our data demonstrate that PD-L1 expression occurs in tumor and immune cells, in areas in which they are close in contact. Interferon seems to play a role in this interaction. We postulate that PD-L1(+)/CD33(+) cells shield the tumor against attacking PD-1(+) immune cells. Therefore, next to anti-PD-1/PD-L1 antibodies, blockade of CD33 seems to be a promising therapeutic approach. © 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Berisha, A. (author)
  • Tronnier, M. (author)
  • Pfaltz, Monique C.Mittuniversitetet,Institutionen för psykologi och socialt arbete(Swepub:miun)monpfa (author)
  • Kempf, W. (author)
  • MittuniversitetetInstitutionen för psykologi och socialt arbete (creator_code:org_t)

Related titles

  • In:Journal of cutaneous pathology: Blackwell Publishing Ltd44:9, s. 740-7460303-69871600-0560

Internet link

Find in a library

To the university's database

Find more in SwePub

By the author/editor
Mitteldorf, C.
Berisha, A.
Tronnier, M.
Pfaltz, Monique ...
Kempf, W.
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Health Sciences
and Other Health Sci ...
Articles in the publication
Journal of cutan ...
By the university
Mid Sweden University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view